Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00369954
Status:
WITHDRAWN
Last Update Posted:
2013-06-10
First Post:
2006-08-29
Brief Title:
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer Primary Peritoneal Cancer or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin
Sponsor:
Gynecologic Oncology Group
Organization:
GOG Foundation
Organization Data
Organization:
GOG Foundation
Class:
NETWORK
Study ID:
CDR0000496764
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gynecologic Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Philip J DiSaia
Old Organization:
Gynecologic Oncology Group
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |